Furthermore, the influence of leptin-induced EMT is not confined to breast cancer; it has also been well documented in various other cancer types, including esophageal adenocarcinoma, cholangiocarcinoma, lung cancer, and prostate cancer. This evidence concerns the gene LEP and esophageal adenocarcinoma.